89 related articles for article (PubMed ID: 25814055)
1. An interview with Nora Volkow.
Volkow ND
Trends Pharmacol Sci; 2015 Apr; 36(4):187-8. PubMed ID: 25814055
[No Abstract] [Full Text] [Related]
2. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
Dwoskin LP
Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
[No Abstract] [Full Text] [Related]
3. Nora Volkow--challenging the myths about drug addiction.
Shetty P
Lancet; 2011 Aug; 378(9790):477. PubMed ID: 21821175
[No Abstract] [Full Text] [Related]
4. Nora Volkow profile. New head of drug institute is wired for action.
Kaiser J
Science; 2003 Jul; 301(5629):39-40. PubMed ID: 12843373
[No Abstract] [Full Text] [Related]
5. Planning the new national institute on substance use and addiction disorders.
Nestler EJ; Krystal JH
Biol Psychiatry; 2012 Aug; 72(3):166-7. PubMed ID: 22683089
[No Abstract] [Full Text] [Related]
6. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
Li MD; Hser YI; Chen Z; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
[TBL] [Abstract][Full Text] [Related]
7. Nora Volkow, MD: NIDA's new leader: from rejection to direction.
Vastag B
JAMA; 2003 Nov; 290(20):2647-52. PubMed ID: 14645294
[No Abstract] [Full Text] [Related]
8. Partnerships in drug abuse prevention services research: perspectives from the National Institute on Drug Abuse.
Robertson EB; Sims BE; Reider EE
Adm Policy Ment Health; 2012 Jul; 39(4):327-30. PubMed ID: 22203328
[No Abstract] [Full Text] [Related]
9. Nora Volkow: motivated neuroscientist.
Volkow N
Mol Interv; 2004 Oct; 4(5):243-7. PubMed ID: 15471905
[TBL] [Abstract][Full Text] [Related]
10. A note from NIDA's director. Images and interventions.
Volkow ND
Sci Pract Perspect; 2007 Apr; 3(2):2-3. PubMed ID: 18092401
[No Abstract] [Full Text] [Related]
11. Plan for addiction institute splits NIH.
Wadman M
Nature; 2010 Oct; 467(7316):643. PubMed ID: 20930813
[No Abstract] [Full Text] [Related]
12. Frontiers in addiction research: celebrating the 35th anniversary of the National Institute on Drug Abuse. Sponsor's foreword.
Shurtleff D; Liu R; Sasek C
Neuropharmacology; 2009; 56 Suppl 1():1-2. PubMed ID: 18789343
[No Abstract] [Full Text] [Related]
13. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
Grabowski J
Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
[TBL] [Abstract][Full Text] [Related]
14. Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trial Network--now, what's new for the coming decade?
McLellan AT
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S1-3. PubMed ID: 20307790
[No Abstract] [Full Text] [Related]
15. Inaugural special issue in research translation.
Tarter R
Am J Drug Alcohol Abuse; 2009; 35(4):205. PubMed ID: 20180670
[No Abstract] [Full Text] [Related]
16. Toward optimal health: Kathleen Brady, Ph.D., M.D., discusses challenges of substance abuse in women. Interview by Jodi R. Godfrey.
Brady K
J Womens Health (Larchmt); 2007 Mar; 16(2):163-7. PubMed ID: 17388732
[No Abstract] [Full Text] [Related]
17. Identifying substance abuse in primary care.
Haverkos HW; Stein MD
Am Fam Physician; 1995 Nov; 52(7):2029-35. PubMed ID: 7484704
[TBL] [Abstract][Full Text] [Related]
18. Blending research and practice: an evolving dissemination strategy in substance abuse.
Michel ME; Pintello DA; Subramaniam G
Soc Work Public Health; 2013; 28(3-4):302-12. PubMed ID: 23731421
[TBL] [Abstract][Full Text] [Related]
19. Sponsor's foreword: NIDA at forty.
Shurtleff D; Sasek C; Kautz M
Neuropharmacology; 2014 Jan; 76 Pt B():195-7. PubMed ID: 23994442
[No Abstract] [Full Text] [Related]
20. Our map should correspond with the territory.
Humphreys K
Addiction; 2010 Dec; 105(12):2054-6; discussion 2056. PubMed ID: 21105304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
